Refers to a compound of formula (i) wherein: AR - CH2 - CH2 - NH Group is a Union of beta adrenoreceptor R2, R3, R4, R4, R5 and R6 are each H or alkyl of C1 - 6 r1 is (i) a phenyl Ring or a heteroaryl Ring 5 or 6 members, (ii) a FUSED bicyclic Ring System (iii) an alkyl group C1 - 6 optionally substituted containing up to two heteroatoms selected from o, s or n,Where the alkyl group can be substituted with the Ring Systems (i) and (ii), R6 is a Aromatic or non Aromatic Heterocyclic Ring of 5 or 6 members containing up to two heteroatoms selected from N, o and S a C1 alkyl group substituted with aryl or heteroaryl - 8 among others.K is 0 OR 1 C (OR) or s (OR) 2 b is alquileno c1-4 alkyl, optionally substituted with up to two groups C1 - 3 Q is o, S, or nr7 R7 is H or alkyl of C1 - 6 l is a linear chain or Chain hidrocarbilo branched C1 - 9 L1, L2, L3 and L4 are independently h, alkyl or cycloalkyl C3 C1 - 6 - 6 h X is 0 OR 1 orS (o) 0 - 2 or cr12r13 W is cr12r13 - cr12r13 or cr12r13 - cr12r13 - cr12r13 R12 and R13 is each h, fluoro, among others, V and Z are a Link, cr12r13, among others and (c), SO2, among others M is 0, 1, 2 or 3 n is 0, 1, 2, 3, or 4, provided that m + N is greater than or equal to 2. It also relates to a Pharmaceutical Composition and a Preparation Process.This Compound is a Beta adrenergic receptor agonist AND anticholinergic, being useful in the treatment of pulmonary DisordersSE REFIERE A UN COMPUESTO DE FORMULA (I) DONDE: AR-CH2-CH2-NH ES UN GRUPO DE UNION BETA -ADRENORECEPTOR R2, R3, R4, R4, R5 Y R5 SON CADA UNO H O ALQUILO C1-6 R1 ES i) UN ANILLO FENILO O UN ANILLO HETEROARILO DE 5 O 6 MIEMBROS, ii) UN SISTEMA FUSIONADO DE ANILLOS BICICLICOS iii) UN GRUPO ALQUILO C1-6 OPCIONALMENTE SUSTITUIDO QUE CONTIENE HASTA DOS HETEROATOMOS SELECCIONADOS ENTRE O, S O N, Y DONDE DICHO GRUPO ALQUILO PUEDE SUSTITUIRSE CON LOS SISTEMAS DE ANILLOS DE (i) Y (ii) R6 ES UN ANILLO HETEROCICLICO AROMATICO O NO AROMATICO DE 5 O 6 MIEMBROS QUE CONTIENE HASTA DOS HE
